![Real ALTUVIIO patient David](/_next/image?url=https%3A%2F%2Fmagnolia-public.prod.accelerator.sanofi%2Fdam%2Fjcr%3A7769f4de-14b8-45b3-9de0-9779591d510a%2FSALT-Peers-David.webp&w=430&q=75)
Meet David
“I was diagnosed with hemophilia A at just 3 months old. Throughout my childhood, I longed to be a kid and take the stairs 2 (or even 3) at a time- an activity others didn't have to think twice about. But frequent ankle bleeds led me to walk with a cane at just 14 years old.
In college, I decided to pursue my passion for opera performance. Performing on stage is physically demanding. Because of the high-risk activities I engaged in, I was required to infuse multiple times a week.
After hearing about once-weekly ALTUVIIIO, I immediately asked my doctor about switching treatment. I was excited to learn that ALTUVIIIO prophylaxis was shown to have higher-for-longer factor levels in the near-normal to normal range (over 40%) for most of the week and a 48-hour half-life in adults-which meant I'd have to infuse only once a week.
Offstage, I use my voice for advocacy. I hope that people with hemophilia will work with their doctors to find the right treatment plan for them and their lifestyles, just like I did!"
David is a promotional speaker compensated by Sanofi and received free product through Sanofi's Patient Support Program.
“I was diagnosed with hemophilia A at just 3 months old. Throughout my childhood, I longed to be a kid and take the stairs 2 (or even 3) at a time- an activity others didn't have to think twice about. But frequent ankle bleeds led me to walk with a cane at just 14 years old.
In college, I decided to pursue my passion for opera performance. Performing on stage is physically demanding. Because of the high-risk activities I engaged in, I was required to infuse multiple times a week.
After hearing about once-weekly ALTUVIIIO, I immediately asked my doctor about switching treatment. I was excited to learn that ALTUVIIIO prophylaxis was shown to have higher-for-longer factor levels in the near-normal to normal range (over 40%) for most of the week and a 48-hour half-life in adults-which meant I'd have to infuse only once a week.
Offstage, I use my voice for advocacy. I hope that people with hemophilia will work with their doctors to find the right treatment plan for them and their lifestyles, just like I did!"
David is a promotional speaker compensated by Sanofi and received free product through Sanofi's Patient Support Program.
Hear from more patients
![Real ALTUVIIO patient Harrison and his mom/caregiver Ashley](/_next/image?url=https%3A%2F%2Fmagnolia-public.prod.accelerator.sanofi%2Fdam%2Fjcr%3A6a948740-d08c-4348-b6f6-d3d5c2d618f2%2FSALT-Peers-Ashley-Harrison.webp&w=2560&q=75)
![Real ALTUVIIO patient Chris](/_next/image?url=https%3A%2F%2Fmagnolia-public.prod.accelerator.sanofi%2Fdam%2Fjcr%3Aac1bb123-92f3-4355-9828-e626e4526b4f%2FSALT-Peers-Chris.webp&w=2560&q=75)
![A mom and caregiver to 14-year-old Zander, who switched to ALTUVIIIO in 2023 and is starting to take charge of his treatment.](/_next/image?url=https%3A%2F%2Fmagnolia-public.prod.accelerator.sanofi%2Fdam%2Fjcr%3A70762659-21d1-4e9c-8ae2-2ff7bd6f9bc9%2FALTUVIIIO-dot-com_Patient-Stories-Page_NikaandZander_06042024.webp&w=2560&q=75)